Evaluation of preoperative clinical and translational selection criteria for cytoreductive surgery in endometrial cancer - A retrospective multicenter trial with an accompanying translational project
- Conditions
- C54.1Endometrium
- Registration Number
- DRKS00032412
- Lead Sponsor
- AGO Research GmbH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 800
Inclusion Criteria
Patients =18 years undergoing cytoreductive surgery for endometrial cancer between 01/2011 and 12/2020 with the following criteria:
- Primary diagnosis of advanced endometrial cancer and peritoneal metastases (FIGO IV) undergoing cytoreductive surgery
OR
- Diagnosis of recurrent endometrial cancer undergoing cytoreductive surgery Optional but strongly encouraged for translational part:
availability of FFPE tumor material from cytoreductive surgery
Exclusion Criteria
1. Patients with past medical history interfering with radical cytoreductive surgery
2. Patients undergoing surgery solely for palliative intent
3. Patients with secondary
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method